Cancer exosomes express CD39 and CD73, which suppress T cells through adenosine production - PubMed (original) (raw)
. 2011 Jul 15;187(2):676-83.
doi: 10.4049/jimmunol.1003884. Epub 2011 Jun 15.
Affiliations
- PMID: 21677139
- DOI: 10.4049/jimmunol.1003884
Cancer exosomes express CD39 and CD73, which suppress T cells through adenosine production
Aled Clayton et al. J Immunol. 2011.
Abstract
Extracellular adenosine is elevated in cancer tissue, and it negatively regulates local immune responses. Adenosine production from extracellular ATP has attracted attention as a mechanism of regulatory T cell-mediated immune regulation. In this study, we examined whether small vesicles secreted by cancer cells, called exosomes, contribute to extracellular adenosine production and hence modulate immune effector cells indirectly. We found exosomes from diverse cancer cell types exhibit potent ATP- and 5'AMP-phosphohydrolytic activity, partly attributed to exosomally expressed CD39 and CD73, respectively. Comparable levels of activity were seen with exosomes from pleural effusions of mesothelioma patients. In such fluids, exosomes accounted for 20% of the total ATP-hydrolytic activity. Exosomes can perform both hydrolytic steps sequentially to form adenosine from ATP. This exosome-generated adenosine can trigger a cAMP response in adenosine A(2A) receptor-positive but not A(2A) receptor-negative cells. Similarly, significantly elevated cAMP was also triggered in Jurkat cells by adding exosomes with ATP but not by adding exosomes or ATP alone. A proportion of healthy donor T cells constitutively express CD39 and/or CD73. Activation of T cells by CD3/CD28 cross-linking could be inhibited by exogenously added 5'AMP in a CD73-dependent manner. However, 5'AMP converted to adenosine by exosomes inhibits T cell activation independently of T cell CD73 expression. This T cell inhibition was mediated through the adenosine A(2A) receptor. In summary, the data highlight exosome enzymic activity in the production of extracellular adenosine, and this may play a contributory role in negative modulation of T cells in the tumor environment.
Similar articles
- Human tumor-derived exosomes selectively impair lymphocyte responses to interleukin-2.
Clayton A, Mitchell JP, Court J, Mason MD, Tabi Z. Clayton A, et al. Cancer Res. 2007 Aug 1;67(15):7458-66. doi: 10.1158/0008-5472.CAN-06-3456. Cancer Res. 2007. PMID: 17671216 - Generation of anti-inflammatory adenosine by leukocytes is regulated by TGF-β.
Regateiro FS, Howie D, Nolan KF, Agorogiannis EI, Greaves DR, Cobbold SP, Waldmann H. Regateiro FS, et al. Eur J Immunol. 2011 Oct;41(10):2955-65. doi: 10.1002/eji.201141512. Epub 2011 Sep 6. Eur J Immunol. 2011. PMID: 21770045 - Human CD4+ CD39+ regulatory T cells produce adenosine upon co-expression of surface CD73 or contact with CD73+ exosomes or CD73+ cells.
Schuler PJ, Saze Z, Hong CS, Muller L, Gillespie DG, Cheng D, Harasymczuk M, Mandapathil M, Lang S, Jackson EK, Whiteside TL. Schuler PJ, et al. Clin Exp Immunol. 2014 Aug;177(2):531-43. doi: 10.1111/cei.12354. Clin Exp Immunol. 2014. PMID: 24749746 Free PMC article. - Generation and Function of Non-cell-bound CD73 in Inflammation.
Schneider E, Rissiek A, Winzer R, Puig B, Rissiek B, Haag F, Mittrücker HW, Magnus T, Tolosa E. Schneider E, et al. Front Immunol. 2019 Jul 26;10:1729. doi: 10.3389/fimmu.2019.01729. eCollection 2019. Front Immunol. 2019. PMID: 31404305 Free PMC article. Review. - CD73 and adenosine generation in the creation of regulatory microenvironments.
Regateiro FS, Cobbold SP, Waldmann H. Regateiro FS, et al. Clin Exp Immunol. 2013 Jan;171(1):1-7. doi: 10.1111/j.1365-2249.2012.04623.x. Clin Exp Immunol. 2013. PMID: 23199317 Free PMC article. Review.
Cited by
- Exosome therapeutics for non-small cell lung cancer tumorigenesis.
Orooji N, Fadaee M, Kazemi T, Yousefi B. Orooji N, et al. Cancer Cell Int. 2024 Oct 30;24(1):360. doi: 10.1186/s12935-024-03544-6. Cancer Cell Int. 2024. PMID: 39478574 Free PMC article. Review. - The potential role of purinergic signaling in cancer therapy: perspectives on anti-CD73 strategies for prostate cancer.
Gardani CFF, Diz FM, Dondé LB, Rockenbach L, Laufer S, Morrone FB. Gardani CFF, et al. Front Immunol. 2024 Sep 17;15:1455469. doi: 10.3389/fimmu.2024.1455469. eCollection 2024. Front Immunol. 2024. PMID: 39355246 Free PMC article. Review. - Composition, functions, and applications of exosomal membrane proteins.
Xu F, Luo S, Lu P, Cai C, Li W, Li C. Xu F, et al. Front Immunol. 2024 Aug 1;15:1408415. doi: 10.3389/fimmu.2024.1408415. eCollection 2024. Front Immunol. 2024. PMID: 39148736 Free PMC article. Review. - Assessment of ATP metabolism to adenosine by ecto-nucleotidases carried by tumor-derived small extracellular vesicles.
Hong CS, Menshikova EV, Whiteside TL, Jackson EK. Hong CS, et al. Purinergic Signal. 2024 Jul 27. doi: 10.1007/s11302-024-10038-7. Online ahead of print. Purinergic Signal. 2024. PMID: 39066830 - Extracellular vesicles from seminal plasma interact with T cells in vitro and drive their differentiation into regulatory T-cells.
Zhang X, Greve PF, Minh TTN, Wubbolts R, Demir AY, Zaal EA, Berkers CR, Boes M, Stoorvogel W. Zhang X, et al. J Extracell Vesicles. 2024 Jul;13(7):e12457. doi: 10.1002/jev2.12457. J Extracell Vesicles. 2024. PMID: 39007430 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous